These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33776763)

  • 1. The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function
    Hering NA; Luettig J; Jebautzke B; Schulzke JD; Rosenthal R
    Front Pharmacol; 2021; 12():610164. PubMed ID: 33776763
    [No Abstract]   [Full Text] [Related]  

  • 2. Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells.
    Rosenthal R; Luettig J; Hering NA; Krug SM; Albrecht U; Fromm M; Schulzke JD
    Int J Colorectal Dis; 2017 May; 32(5):623-634. PubMed ID: 27981377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebeccamycin Attenuates TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Inhibiting Myosin Light Chain Kinase Production.
    Watari A; Sakamoto Y; Hisaie K; Iwamoto K; Fueta M; Yagi K; Kondoh M
    Cell Physiol Biochem; 2017; 41(5):1924-1934. PubMed ID: 28391269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pomegranate polyphenols and urolithin A inhibit α-glucosidase, dipeptidyl peptidase-4, lipase, triglyceride accumulation and adipogenesis related genes in 3T3-L1 adipocyte-like cells.
    Les F; Arbonés-Mainar JM; Valero MS; López V
    J Ethnopharmacol; 2018 Jun; 220():67-74. PubMed ID: 29604377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species.
    Selma MV; Beltrán D; García-Villalba R; Espín JC; Tomás-Barberán FA
    Food Funct; 2014 Aug; 5(8):1779-84. PubMed ID: 24909569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells.
    Qiu Z; Zhou B; Jin L; Yu H; Liu L; Liu Y; Qin C; Xie S; Zhu F
    Food Chem Toxicol; 2013 Sep; 59():428-37. PubMed ID: 23811531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ellagic acid and its fermentative derivative urolithin A show reverse effects on the gp91-phox gene expression, resulting in opposite alterations in all-
    Kikuchi H; Harata K; Madhyastha H; Kuribayashi F
    Biochem Biophys Rep; 2021 Mar; 25():100891. PubMed ID: 33490645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of Human Intestinal Bacteria Capable of Producing the Bioactive Metabolite Isourolithin A from Ellagic Acid.
    Selma MV; Beltrán D; Luna MC; Romo-Vaquero M; García-Villalba R; Mira A; Espín JC; Tomás-Barberán FA
    Front Microbiol; 2017; 8():1521. PubMed ID: 28824607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer
    Lu Y; Li L; Zhang JW; Zhong XQ; Wei JA; Han L
    World J Gastroenterol; 2018 Jul; 24(26):2867-2877. PubMed ID: 30018481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.
    Fischer A; Gluth M; Pape UF; Wiedenmann B; Theuring F; Baumgart DC
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G970-9. PubMed ID: 23538493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin protects against intestinal inflammation and bacteria-induced barrier dysfunction in vitro.
    Hering NA; Luettig J; Krug SM; Wiegand S; Gross G; van Tol EA; Schulzke JD; Rosenthal R
    Ann N Y Acad Sci; 2017 Oct; 1405(1):177-188. PubMed ID: 28614589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
    Moran GW; O'Neill C; McLaughlin JT
    Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity.
    Contreras TC; Ricciardi E; Cremonini E; Oteiza PI
    Arch Biochem Biophys; 2015 May; 573():84-91. PubMed ID: 25795020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
    Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
    Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption and Metabolism of Urolithin A and Ellagic Acid in Mice and Their Cytotoxicity in Human Colorectal Cancer Cells.
    Lin IC; Wu JY; Fang CY; Wang SC; Liu YW; Ho ST
    Evid Based Complement Alternat Med; 2023; 2023():8264716. PubMed ID: 37706115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.
    Jin Y; Blikslager AT
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C996-C1004. PubMed ID: 27760753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strawberry processing does not affect the production and urinary excretion of urolithins, ellagic acid metabolites, in humans.
    Truchado P; Larrosa M; García-Conesa MT; Cerdá B; Vidal-Guevara ML; Tomás-Barberán FA; Espín JC
    J Agric Food Chem; 2012 Jun; 60(23):5749-54. PubMed ID: 22126674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Autophagic Degradation Process Contributes to Claudin-2 Expression Increase and Epithelial Tight Junction Dysfunction in TNF-α Treated Cell Monolayers.
    Zhang C; Yan J; Xiao Y; Shen Y; Wang J; Ge W; Chen Y
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradation of Punicalagin into Ellagic Acid by Selected Probiotic Bacteria: A Study of the Underlying Mechanisms by MS-Based Proteomics.
    Caballero V; Estévez M; Tomás-Barberán FA; Morcuende D; Martín I; Delgado J
    J Agric Food Chem; 2022 Dec; 70(51):16273-16285. PubMed ID: 36519204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic acid and intestinal microflora metabolite urolithin A: A review on its sources, metabolic distribution, health benefits, and biotransformation.
    Zhang M; Cui S; Mao B; Zhang Q; Zhao J; Zhang H; Tang X; Chen W
    Crit Rev Food Sci Nutr; 2023; 63(24):6900-6922. PubMed ID: 35142569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.